Identification of a BCG Vaccination Scar

Characteristics and Appearance of a BCG Scar

The BCG vaccination scar is a common identifier of tuberculosis immunization. It appears as a small, distinct mark on the upper arm, forming due to localized immune responses.

6/7/20253 min read29 views
loved it
normalintermediateRespiratory Medicine
Identification of a BCG Vaccination Scar – Medical Insights

Identification of a BCG Vaccination Scar

Characteristics and Appearance of a BCG Scar

The Bacillus Calmette–Guérin (BCG) vaccine, primarily used to protect against tuberculosis, often leaves a distinct scar at the site of injection. Recognizing this scar can be important for medical assessments and epidemiological studies.

Appearance of a BCG Scar

  • A well-defined circular or oval mark
  • Usually 4-10 mm in diameter
  • Located on the upper arm, typically the deltoid region
  • May have a slightly raised or depressed surface

Why Does the Scar Form?

The BCG vaccine, which contains a live attenuated strain of Mycobacterium bovis, triggers an immune response leading to localized inflammation. This inflammatory process results in tissue necrosis and subsequent scarring.

Clinical Significance

Medical professionals often check for a BCG scar to confirm prior vaccination. The presence of a scar can influence tuberculosis screening protocols and affect diagnostic interpretations.

Scar Variability

Factors affecting scar formation include:

  • Age at vaccination
  • Technique of administration
  • Individual immune response

Tags

#BCG vaccination#Tuberculosis prevention#Respiratory medicine#Vaccination scar

0 people loved it

Recommended Reads

Explore related articles that might interest you

Indications and limitations of culturing Mycobacterium tuberculosis
24
11%

Indications and limitations of culturing Mycobacterium tuberculosis

Read more →
24
Indications and limitations of culturing Mycobacterium tuberculosis
39
11%

Indications and limitations of culturing Mycobacterium tuberculosis

Read more →
39
Epidemiology, predisposing factors, and therapeutic considerations in drug resistance
18
11%

Epidemiology, predisposing factors, and therapeutic considerations in drug resistance

Read more →
18
Indications and limitations of culturing Mycobacterium tuberculosis
7
11%

Indications and limitations of culturing Mycobacterium tuberculosis

Read more →
7
Smoking Cessation Counseling
32
11%

Smoking Cessation Counseling

Read more →
32
Management of Acute Exacerbations of Respiratory Conditions
39
11%

Management of Acute Exacerbations of Respiratory Conditions

Read more →
39
Training health care workers on national tuberculosis programs and the Directly Observed Treatment, Short-course (DOTS) strategy
24
11%

Training health care workers on national tuberculosis programs and the Directly Observed Treatment, Short-course (DOTS) strategy

Read more →
24
© 2025 MedGloss. All rights reserved.